Tectorigenin

Tectorigenin is a bioactive isoflavone compound found in plants like Pueraria thunbergiana that demonstrates anti-cancer and anti-fibrotic properties. It works primarily by modulating microRNA expression and inhibiting key enzymes like tyrosinase.

Origin & History

Tectorigenin is an O-methylated isoflavone found in plants such as Belamcanda chinensis and Pueraria thunbergiana. It is produced as a purified compound isolated from plant materials like rhizomes and flowers, often as an aglycone metabolite of glycosides such as tectoridin.

Historical & Cultural Context

Tectorigenin is abundant in Belamcandae Rhizoma and Puerariae flos, plants used in traditional Chinese medicine. However, tectorigenin itself is referenced primarily as a modern isolated compound rather than a traditionally prepared one.

Health Benefits

• Inhibits abnormal proliferation of pulmonary fibroblasts, enhancing miR-338* expression (in vitro study).
• Shows potential as a tyrosinase inhibitor (preclinical study).
• Induces differentiation and apoptosis in cancer cells (in vitro study from Pueraria thunbergiana).
• Exhibits stronger antioxidant activity and prostaglandin E2 inhibition than tectoridin (preclinical evidence).
• Reduces palmitic acid-stimulated ROS production, affecting pathways like MAPK/ERK (preclinical research).

How It Works

Tectorigenin enhances miR-338* expression, which inhibits abnormal pulmonary fibroblast proliferation and reduces fibrosis development. The compound also acts as a tyrosinase inhibitor, blocking melanin synthesis pathways. Additionally, it induces cancer cell differentiation and apoptosis through modulation of cellular signaling cascades.

Scientific Research

No human clinical trials or meta-analyses on tectorigenin are available. Current research is limited to in vitro and preclinical studies, indicating the need for further investigation in clinical settings.

Clinical Summary

Current evidence for tectorigenin comes exclusively from in vitro and preclinical studies with no human clinical trials available. Laboratory studies show significant anti-proliferative effects on pulmonary fibroblasts and cancer cell lines. The compound demonstrates stronger antioxidant activity compared to some reference compounds in cell culture models. Human studies are needed to establish clinical efficacy, safety profiles, and optimal dosing protocols.

Nutritional Profile

Tectorigenin is a naturally occurring isoflavone aglycone (molecular formula: C16H12O6; molecular weight: 300.26 g/mol), not a conventional food ingredient with macronutrient or micronutrient content. It is a bioactive secondary metabolite found in plants such as Belamcanda chinensis (blackberry lily rhizome), Pueraria thunbergiana, Iris tectorum, and Foeniculum vulgare. As a pure compound, it contains no meaningful macronutrients (proteins, fats, carbohydrates), micronutrients (vitamins, minerals), or caloric value in pharmacologically relevant doses. Key bioactive characteristics include: isoflavone backbone with hydroxyl groups at C-5, C-7, and C-4' positions and a methoxy group at C-6, contributing to its antioxidant and enzyme-inhibitory properties; it is the aglycone form of tectorigenin glycoside (tectoridin), formed via hydrolysis. Bioavailability notes: as an aglycone, tectorigenin is more readily absorbed than its glycoside precursor tectoridin, as it does not require intestinal glycosidase activity for deglycosylation prior to absorption; lipophilicity (logP ~2.5–3.0) facilitates passive intestinal permeability; however, extensive Phase I/II hepatic metabolism (glucuronidation, sulfation) and efflux transport may limit systemic bioavailability; protein binding is significant (~85–90% estimated); typical experimental concentrations used in preclinical studies range from 1–100 µM in vitro and 10–100 mg/kg in animal models. No established dietary reference intake or tolerable upper limit exists.

Preparation & Dosage

No clinically studied dosage ranges are available from the current research. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Resveratrol, Curcumin, EGCG, Luteolin

Safety & Interactions

No human safety data exists for tectorigenin supplementation, as research remains limited to laboratory studies. Potential interactions with medications metabolized by cytochrome P450 enzymes cannot be ruled out given its isoflavone structure. Pregnancy and breastfeeding safety is unknown due to lack of clinical data. Individuals with hormone-sensitive conditions should exercise caution given tectorigenin's isoflavone classification.